The United States Oncology Clinical Trials Market holds a dominant position globally, driven by a highly advanced healthcare ecosystem, strong presence of leading pharmaceutical and biotechnology companies, and significant investment in cancer research and development. The country continues to lead in the adoption of cutting-edge oncology therapies, including immunotherapy, targeted therapy,...